Patent ID: 6462071
Filing Date: 2002-10-08
Classification: A61K,Y10S

Abstract:
A method for treating a disorder of the eye for a purpose selected from the group consisting of;inducing posterior vitreous detachment and/or disinsertion of the vitreous body from the retina and epiretinal membranes; calling non-enzymatic dissolution of the hyaloid membrane; causing liquefaction of the vitreous humor; causing diffusion or preventing the accumulation of localized concentrations near the retina of substances that are injurious or pathogenic to the retina, causing dissolution of coagulum within the vitreous humor; treating diabetic retnopathy; treating intravitreal hemorrhage and accelerating the clearance of hemorrhagic blood from the vitreous humor; treating vitreous traction associated with macular holes; treating macular degeneration; treat retinitis pigmentosa; prophylaexis to retinal detachment in patients who are at high risk for retinal detachment; treating preretinal and subretinal membranes; improving the delivery to the retina and preretinal tissues of intravitreally administered drugs; and, as an adjunct to a vitrectomy procedure, the method comprising the step of (A) injecting intravitreally a therapeutically effective amount of a compound comprising urea.